Sergio Guerrero,
MD
Former President/CEO
Accelerium Clinical Research
Dr. Guerrero is the former President/Chief Executive Officer of Accelerium Clinical Research, where clinical trials are conducted for the local and international pharmaceutical and biotechnology industry in phase 1-4, and bioequivalence studies for new drug and medical devices development in accordance with the US Food & Drug Administration and International Council on Harmonisation good clinical practice guidelines and local regulations. Previously, he was the Director of the Monterrey International Clinical Research Center/OCA Hospital where he was responsible for the research unit to manage a multi-specialty investigator network to conduct clinical trials for the international pharmaceutical and clinical research organization industry. Dr. Guerrero has also been the Director of Latin America for INC Research, a clinical research organization based in Raleigh, North Carolina; and Director of the Mexican Institute for Clinical Research, a site management organization in Mexico City. He has more than 18 years of experience in clinical research working as a Director, Investigator, Project Manager and Quality Assurance Auditor/Inspector for the international pharmaceutical/ clinical research organization/site management organization industry, developing and implementing processes and procedures to train and manage clinical teams, and monitor the conduct of clinical trials.
Throughout, Dr. Guerrero has been involved in organizing, conducting, and managing clinical trials from phase 1-4 in most therapeutic areas, including endocrinology, dermatology, oncology, infectious disease, neurology, hematology, pediatrics, cardiovascular, biologics, and medical devices. Recently, he has been involved with international organizations developing areas of opportunity in Latin America to conduct clinical trials, and coordinating seminars and scientific events related to the pharmaceutical industry and good clinical practices-International Council on Harmonisation guidelines among medical professionals.
Dr. Guerrero initiated his research career in Bethesda, MD (USA), participating in the organ/tissue transplant technology development that later led him to conduct medical research for a transplant laboratory, where he was responsible to for coordinating and managing the operation according to the requirements of the US Food and Drug Administration. Dr. Guerrero received his medical degree from the Universidad Autonoma de Ciudad Juarez in Juarez, Mexico.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China